Orgenesis Profile

7.61
USD 0.64  7.76%
7.61
0%
10.15
7.52
12%
8.25

Selected Orgenesis Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Orgenesis Against Markets

Orgenesis Inc., a biopharmaceutical company, develops trans-differentiation technologies in the field of cell therapy and regenerative medicine. Orgenesis Inc. was founded in 2008 and is based in Germantown, Maryland. Orgenesis operates under Business Services classification in USA and traded on OTC Market exchange. It employs 80 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameOrgenesis Inc
CEO of Orgenesis Maryland IncScott CarmerAll Leadership
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMARYLAND, U.S.A
Business Address20271 Goldenrod Lane
ExchangeOTC Market
CUSIP68619K105
SectorServices
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.orgenesis.com
Contact Number480 659 6404
Related EntityBOUT
CurrencyUSD - US Dollar

Directors

Orgenesis Corporate Directors
David Sidransky Director
Yaron Adler Director
Marie Bouillez Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Directors

Orgenesis Corporate Directors
David Sidransky Director
Yaron Adler Director
Marie Bouillez Director